|
1
|
Homburg R: What is polycystic ovarian
syndrome? A proposal for a consensus on the definition and
diagnosis of polycystic ovarian syndrome. Hum Reprod. 17:2495–2499.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Homburg R: The management of infertility
associated with polycystic ovary syndrome. Reprod Biol Endocrinol.
1:1092003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Diamanti-Kandarakis E, Piperi C, Spina J,
Argyrakopoulou G, Papanastasiou L, Bergiele A and Panidis D:
Polycystic ovary syndrome: the influence of environmental and
genetic factors. Hormones (Athens). 5:17–34. 2006. View Article : Google Scholar
|
|
4
|
Mukherjee S and Maitra A: Molecular and
genetic factors contributing to insulin resistance in polycystic
ovary syndrome. Indian J Med Res. 131:743–760. 2010.PubMed/NCBI
|
|
5
|
Prapas N, Karkanaki A, Prapas I,
Kalogiannidis I, Katsikis I and Panidis D: Genetics of polycystic
ovary syndrome. Hippokratia. 13:216–223. 2009.PubMed/NCBI
|
|
6
|
Lenarcik A, Bidzinska-Speichert B and
Tworowska-Bardzinska U: The role of chronic inflammation and
Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary
syndrome. Gynecol Endocrinol. 26:673–683. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Luque-Ramirez M, San Millan JL and
Escobar-Morreale HF: Genomic variants in polycystic ovary syndrome.
Clin Chim Acta. 366:14–26. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martinez-Garcia MA, Luque-Ramirez M,
San-Millan JL and Escobar-Morreale HF: Body iron stores and glucose
intolerance in premenopausal women: role of hyperandrogenism,
insulin resistance, and genomic variants related to inflammation,
oxidative stress, and iron metabolism. Diabetes Care. 32:1525–1530.
2009. View Article : Google Scholar
|
|
9
|
San Millan JL, Alvarez-Blasco F,
Luque-Ramirez M, Botella-Carretero JI and Escobar-Morreale HF: The
PON1-108C/T polymorphism, and not the polycystic ovary syndrome, is
an important determinant of reduced serum paraoxonase activity in
premenopausal women. Hum Reprod. 21:3157–3161. 2006.PubMed/NCBI
|
|
10
|
Mohamadin AM, Habib FA and Elahi TF: Serum
paraoxonase 1 activity and oxidant/antioxidant status in Saudi
women with polycystic ovary syndrome. Pathophysiology. 17:189–196.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fenkci IV, Serteser M, Fenkci S and Kose
S: Paraoxonase levels in women with polycystic ovary syndrome. J
Reprod Med. 52:879–883. 2007.PubMed/NCBI
|
|
12
|
Dursun P, Demirtas E, Bayrak A and Yarali
H: Decreased serum paraoxonase 1 (PON1) activity: an additional
risk factor for atherosclerotic heart disease in patients with
PCOS? Hum Reprod. 21:104–108. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
San Millan JL, Corton M, Villuendas G,
Sancho J, Peral B and Escobar-Morreale HF: Association of the
polycystic ovary syndrome with genomic variants related to insulin
resistance, type 2 diabetes mellitus, and obesity. J Clin
Endocrinol Metab. 89:2640–2646. 2004.PubMed/NCBI
|
|
14
|
Brophy VH, Jampsa RL, Clendenning JB,
McKinstry LA, Jarvik GP and Furlong CE: Effects of 5′
regulatory-region polymorphisms on paraoxonase-gene (PON1)
expression. Am J Hum Genet. 68:1428–1436. 2001.
|
|
15
|
Rotterdam ESHRE/ASRM-Sponsored PCOS
Consensus Workshop Group. Revised 2003 consensus on diagnostic
criteria and long-term health risks related to polycystic ovary
syndrome. Fertil Steril. 81:19–25. 2004. View Article : Google Scholar
|
|
16
|
Balen AH, Laven JS, Tan SL and Dewailly D:
Ultrasound assessment of the polycystic ovary: international
consensus definitions. Hum Reprod Update. 9:505–514. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ly LP and Handelsman DJ: Empirical
estimation of free testosterone from testosterone and sex
hormone-binding globulin immunoassays. Eur J Endocrinol.
152:471–478. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ferk P, Perme MP and Gersak K: Insulin
gene polymorphism in women with polycystic ovary syndrome. J Int
Med Res. 36:1180–1187. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Soyman Z, Noyan V, Tulmac M, Yucel A,
Sagsoz N, Bayrak T and Cakir E: Serum paraoxonase 1 activity,
asymmetric dimethylarginine levels, and brachial artery
flow-mediated dilatation in women with polycystic ovary syndrome.
Fertil Steril. 95:1067–1072. 2011. View Article : Google Scholar
|
|
20
|
Leviev I, Kalix B, Brulhart Meynet MC and
James RW: The paraoxonase PON1 promoter polymorphism C(-107)T is
associated with increased serum glucose concentrations in
non-diabetic patients. Diabetologia. 44:1177–1183. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang F, Liu HW, Fan P, Bai H and Song Q:
The -108 C/T polymorphism in paraoxonase 1 gene in Chinese patients
with polycystic ovary syndrome. J Sichuan Univ Med Sci Ed.
42:24–28. 2011.(In Chinese).
|
|
22
|
Torun AN, Vural M, Cece H, Camuzcuoglu H,
Toy H and Aksoy N: Paraoxonase-1 is not affected in polycystic
ovary syndrome without metabolic syndrome and insulin resistance,
but oxidative stress is altered. Gynecol Endocrinol. 27:988–992.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hughes C, Elgasim M, Layfield R and Atiomo
W: Genomic and post-genomic approaches to polycystic ovary syndrome
- progress so far: Mini Review. Hum Reprod. 21:2766–2775. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Simoni M, Tempfer CB, Destenaves B and
Fauser BC: Functional genetic polymorphisms and female reproductive
disorders: Part I: Polycystic ovary syndrome and ovarian response.
Hum Reprod Update. 14:459–484. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lander ES and Schork NJ: Genetic
dissection of complex traits. Science. 265:2037–2048. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Unluturk U, Harmanci A, Kocaefe C and
Yildiz BO: The genetic basis of the polycystic ovary syndrome: a
literature review including discussion of PPAR-gamma. PPAR Res.
2007:491092007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Skerget AE, Herodez SS, Zagorac A,
Zagradisnik B and Vokac NK: The use of comparative genomic
hybridization as a diagnostic tool in medical genetics
laboratories: first application on different clinical samples. Acta
Medico-Biotechnica. 4:49–56. 2011.
|
|
28
|
Goodarzi MO: Looking for polycystic ovary
syndrome genes: rational and best strategy. Semin Reprod Med.
26:5–13. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pasquali R, Stener-Victorin E, Yildiz BO,
et al: PCOS Forum: research in polycystic ovary syndrome today and
tomorrow. Clin Endocrinol (Oxf). 74:424–433. 2011. View Article : Google Scholar : PubMed/NCBI
|
